Status:
UNKNOWN
Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients
Lead Sponsor:
Stendo
Conditions:
Essential Hypertension
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The action of one Stendo pulsating suit session will be evaluated on 24 patients referred to the hypertension consultations for essential hypertension treated but not stabilized. The effect of one Ste...
Detailed Description
The role of the endothelium in micro-vascular system is mediated by synthesis and release of numerous substances that act on the smooth muscle fibres. The release of these products is modulated, in tu...
Eligibility Criteria
Inclusion
- Patient referred to the Hypertension Hospital Consultation for essential hypertension treated but not stabilized
- Patient with essential hypertension defined by a brachial arterial pressure of 140 ≤ Systolic Arterial Pressure \< 180 mm Hg and/or 90 ≤ Diastolic Arterial - Pressure \< 110 mm Hg
- Essential Hypertension confirmed by an ambulatory measure of the arterial pressure during 24 hours before the pre-inclusion visit
- Patients aged more than 40 and less than 70
Exclusion
- Patient with secondary hypertension
- Patient with diabetes
- Patient with complete arrhythmia with atrial fibrillation
- Patient with an advanced obstructive arterial disease
- Patient with a recent and progressive deep venous thrombosis
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02277821
Start Date
October 1 2014
End Date
July 1 2015
Last Update
May 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Lariboisière - Service de Physiologie Clinique - Explorations Fonctionnelles
Paris, France, 75010